Richard D. Kim, Xiaozhou Fan, Javier Sabater, Wayne Su, Kathleen Hurwitz, Kayla Hendrickson, Kara Bennett, Catherine Wiener, Phillip M. Garfin, Joan Zape, Mark Ozog, John Bridgewater, Juan W. Valle, Farshid Dayyani. "Survival outcomes for zanidatamab-hrii compared to chemotherapy in previously treated HER2-positive (IHC3+) biliary tract cancer (BTC): HERIZON-BTC-01 vs a real-world (RW) external control arm (ECA).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4101